[Combined cytostatic therapy in the treatment of acute leukemias].
It was analysed 66 patients with different types of acute leukaemias treated on haematological department of Internal Clinics Mylitary Medical Academy during 1969-1974 years with combination chemotherapy. At 35 patients with acute lymphoblastic leukaemias it was obtain complete remission at 60%, and partial remission at 28,5%. Without the response was 11,4% patients. At 20 patients with acute myeloid leukaemias were induced only partial remission at 4 0% patients, and 60% patients were without the therapeutic response. The survival of patients with acute leukemias is presented. 88,4% patients with acute lymphoblastic leukaemias survived to two years, and 61,5% patients with acute myeloid leukaemias survived only to three months. None of the patients with acute myeloid leukaemias survived over one year.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011241:Prednisone
Kombinovana citostatska terapija u lecenju akutnih leukemija